Some people use these medications just during the first few days at new dose levels to make the adjustment period more tolerable
This way, your body can adjust to the medication gradually
At those levels, receptor activation may still occur, but the intensity of the signal is smaller and less predictable
Over time, sticking to new routines can be challenging, and occasional slip-ups are normal
These results, combined with orforgliprons once-daily oral dosing and broad scalability, reinforce its potential as a foundational treatment for type 2 diabetes. Eli Lilly also recently presented detailed results from the ATTAIN-1 trial, which investigated orforglipron in adults with obesity or overweight without diabetes, at the European Association for the Study of Diabetes (EASD) Annual Meeting 2025
Saxenda requires more frequent injections than Ozempic